Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CUMBERLAND PHARMACEUTICALS INC Director's Dealing 2012

May 24, 2012

34617_dirs_2012-05-24_11dfa65c-ee30-46ca-b405-1e0ec7cdfda1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK: 0001087294
Period of Report: 2012-05-22

Reporting Person: KAZIMI A J (Director, Chairman and CEO, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-05-22 Options $14.30 D 30000 Disposed 2008-07-31 Common stock (30000) Direct
2012-05-22 Options $14.30 D 30000 Disposed 2014-02-16 Common stock (30000) Direct
2012-05-22 Options $12.42 D 50000 Disposed 2015-03-26 Common stock (50000) Direct
2012-05-22 Restricted stock $0.00 A 13497 Acquired Common stock (13497) Direct

Footnotes

F1: Vested 25% per year beginning 12/31/08 - 12/31/11.

F2: Vested 25% per year beginning 12/31/09 - 12/31/12.

F3: Vested 25% per year beginning 12/31/10 - 12/31/13

F4: Restricted shares acquired in exchange for options tendered as part of the Exchange Program that ended on May 21, 2012.

F5: Restricted stock does not expire.